Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMFA04000091 Resolvin T1 7,13,20-Trihydroxy-8E,10Z,14E,16Z,18E-docosapentaenoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 378.24 C22H34O5
LMFA04000092 Resolvin T2 7,8,13-Trihydroxy-9E,11E,14E,16Z,19Z-docosapentaenoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 378.24 C22H34O5
LMFA04000093 Resolvin T3 7,12,13-Trihydroxy-8Z,10E,14E,16Z,19Z-docosapentaenoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 378.24 C22H34O5
LMFA04000094 Resolvin T4 7,13-Dihydroxy-8E,10Z,14E,16Z,19Z-docosapentaenoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 362.25 C22H34O4
LMFA04000126 dihomo-TXB2 9S,11,15S-trihydroxy-2,3-dihomo-thromboxa-5Z,13E-dien-1-oic acid Docosanoids [FA04] Other Docosanoids [FA0400] 398.27 C22H38O6
LMFA04000049 docosapentaenoic acid 2E,4E,6E,8E,10E-docosapentaenoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 330.26 C22H34O2
LMFA04000124 11-hydroxy-7Z,9E,13Z,16Z,19Z-docosapentaenoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 346.25 C22H34O3
LMFA04000122 14-Hydroxy-7Z,10Z,12E,16Z-docosatetraenoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 348.27 C22H36O3
LMFA04000101 (5E,7E)-8-[(3aR,4R,5R,7aS)-4-[(1Z,3E)-5-hydroxy-5-oxopenta-1,3-dienyl]-2,3,3a,4,5,7a-hexahydro-1H-inden-5-yl]octa-5,7-dienoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 356.2 C22H28O4
LMFA04000123 14-hydroxy-7Z,10Z,12E,16Z,19Z-docosapentaenoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 346.25 C22H34O3
LMFA04000125 14-hydroxy-4Z,7Z,10Z,12E,16Z-docosapentaenoic acid Docosanoids [FA04] Other Docosanoids [FA0400] 346.25 C22H34O3
LMFA04010524 (+/-)4-F4t-NeuroP (E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010413 10,13-diepi-10-A4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010177 10,13-diepi-10-D4c-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010176 10,13-diepi-10-D4t-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010305 10,13-diepi-10-E4c-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010304 10,13-diepi-10-E4t-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010049 10,13-diepi-10-F4c-NeuroP (R,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010048 10,13-diepi-10-F4t-NeuroP (R,4Z,7Z,11E)-12-((1R,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010477 10,13-diepi-10-J4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010445 10,17-diepi-17-A4-NeuroP (4Z,7Z)-9-((1S,2R)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010245 10,17-diepi-17-D4c-NeuroP (4Z,7Z)-9-((1S,2S,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010244 10,17-diepi-17-D4t-NeuroP (4Z,7Z)-9-((1R,2R,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010373 10,17-diepi-17-E4c-NeuroP (4Z,7Z)-9-((1S,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010372 10,17-diepi-17-E4t-NeuroP (4Z,7Z)-9-((1R,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010117 10,17-diepi-17-F4c-NeuroP (4Z,7Z)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010116 10,17-diepi-17-F4t-NeuroP (4Z,7Z)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010509 10,17-diepi-17-J4-NeuroP (4Z,7Z)-9-((1R,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010415 10-A4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010183 10-D4c-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010186 10-D4t-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010311 10-E4c-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010314 10-E4t-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010005 10-F4-NeuroP (4Z,7Z,11E)-12-(3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010055 10-F4c-NeuroP (S,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010058 10-F4t-NeuroP (S,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010479 10-J4-NeuroP (S,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010411 10-epi-10-A4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,5R)-2-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-3-en-1-yl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010175 10-epi-10-D4c-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010178 10-epi-10-D4t-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,5S)-5-hydroxy-3-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010303 10-epi-10-E4c-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1R,2S,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010306 10-epi-10-E4t-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,2R,3R)-3-hydroxy-5-oxo-2-((Z)-pent-2-en-1-yl)cyclopentyl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010047 10-epi-10-F4c-NeuroP (R,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010050 10-epi-10-F4t-NeuroP (R,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010475 10-epi-10-J4-NeuroP (R,4Z,7Z,11E)-10-hydroxy-12-((1S,5S)-4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)dodeca-4,7,11-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010449 10-epi-17-A4-NeuroP (4Z,7Z)-9-((1S,2R)-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010249 10-epi-17-D4c-NeuroP (4Z,7Z)-9-((1S,2S,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010248 10-epi-17-D4t-NeuroP (4Z,7Z)-9-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010377 10-epi-17-E4c-NeuroP (4Z,7Z)-9-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010376 10-epi-17-E4t-NeuroP (4Z,7Z)-9-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5